Related Experiment Video
Updated: Jan 27, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Necrotizing pneumonia caused by Streptococcus pneumoniae serotype 3 despite PCV13
Gülsüm Alkan1, Melike Emiroğlu2, Hatice T Dağı3
1Facultad de Medicina de Selguk Üniversitesi, Departamento de Infectología Pediátrica, Konya, Turkey. galkan-85@hotmail.com.
Pneumococcal necrotizing pneumonia (PNP) can occur even in fully vaccinated children. This case highlights the risk of breakthrough invasive infections caused by Streptococcus pneumoniae serotype 3.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Streptococcus pneumoniae is a leading cause of complicated pneumonia.
- Pneumococcal necrotizing pneumonia (PNP) is a rare but serious complication linked to specific serotypes.
- Historically, serotypes 1, 3, 14, 15, 19A, and 33 were common in pediatric PNP cases before widespread vaccination.
Observation:
- A case report details a child diagnosed with PNP.
- The child had received the 13-valent pneumococcal conjugate vaccine (PCV13).
- The causative agent was identified as Streptococcus pneumoniae serotype 3.
Findings:
- This case demonstrates a breakthrough invasive infection despite complete vaccination.
- Serotype 3, previously a common cause, remains a threat even post-PCV13 immunization.
- The study underscores that Streptococcus pneumoniae can cause invasive disease irrespective of vaccination status.
Implications:
- Healthcare providers must consider PNP in fully vaccinated children presenting with severe pneumonia.
- The findings suggest the need for ongoing surveillance of pneumococcal serotypes causing invasive disease.
- Vaccine strategies may need to evolve to address breakthrough infections and emerging serotypes.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

